Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
No new research today on managing stage 3 kidney disease
-
Today's research sweep found no studies directly related to chronic kidney disease progression or management.
-
Several studies covered unrelated conditions like tuberculosis, lupus, and heart tumors—none reported kidney-specific outcomes.
-
A health education program for teens and an AI tool for early diabetic kidney damage are still in planning or development stages.
Today brought no published findings relevant to stage 3 chronic kidney disease. Most studies focused on other health issues without kidney outcomes, and the few mind-body or prevention studies did not address kidney health. People with CKD should continue following their current care plan while waiting for more targeted research.
LIFESTYLE AND DIETARY MODIFICATIONS TO PREVENT THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)-A RANDOMIZED CONTROLLED TRIAL ON MIDDLE AGED DIABETIC POPULATION IN DHAKA CITY, BANGLADESH
This was a randomized trial, meaning people were split into groups by chance, which is stronger than simply watching what people choose to do. It tested diet and lifestyle changes meant to slow chronic kidney disease in middle-aged adults with diabetes in Dhaka, Bangladesh. The record available here does not say how many people took part, how long they were followed, or what happened. It is posted on a preprint site and has not been through peer review, so treat the findings as unchecked.
Severe rise in tacrolimus levels following blood orange and grapefruit juice intake in a kidney transplant recipient: a case report.
A 33-year-old man with a kidney transplant had a sharp jump in his blood level of tacrolimus, the drug that keeps his body from attacking the new kidney, after drinking blood orange juice and grapefruit juice. Grapefruit juice is already known to do this: it blocks a gut enzyme (CYP3A4) that breaks the drug down. This report points at blood orange juice too, which had not been reported before. It is a single person, so it shows a link, not proof of cause, but too much tacrolimus can damage the very kidney it is meant to protect.
Medullary pathological findings provide additional prognostic information beyond cortical pathology in native kidney biopsies
When a kidney biopsy is read, doctors mostly examine the outer layer, called the cortex. This study asked whether damage in the deeper part, called the medulla, tells you anything extra about how a person will do later. It found the deeper tissue added information beyond the outer layer alone. It is an observational study of biopsy samples, so it shows a link with later outcomes, not proof of cause, and the number of biopsies is not stated here.
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Finerenone and empagliflozin are two drugs that protect the kidneys, and they are often prescribed together in kidney disease with diabetes. This report asks whether taking both lowers blood pressure more than either alone, and whether the pair is safe together. It comes from a university repository, not a peer reviewed journal, and the abstract was not available. So the study design, the number of people, and the size of any blood pressure drop are all unknown here. Treat it as something to watch for in published form, not as an answer.
Long-term longitudinal evaluation of the sele s128r polymorphism and serum E-selectin levels in autosomal dominant polycystic kidney disease
This study followed people with polycystic kidney disease, an inherited disease that fills the kidneys with fluid sacs called cysts. It tracked a gene variant called SELE S128R and a blood marker of blood vessel stress called E-selectin, to see if either one predicts how fast the kidneys fail. It is an observational study, so it can show a link, not proof that the gene or the marker causes faster decline. The abstract was not available, so the number of people and the length of follow-up are not known here.
Cardiovascular complications in adult patients with chronic kidney disease attending a tertiary hospital in Dodoma, Tanzania; a prospective longitudinal study
Doctors at a hospital in Dodoma, Tanzania followed adults with chronic kidney disease over time and tracked their heart problems. The study reports how often heart complications appeared in this group, in a setting where kidney care research is thin. It is observational, so it shows what happened alongside kidney disease, not what caused it. The record here carries no abstract, so the number of patients and the length of follow up are not known.
Repurposing a prostate tumor marker: elevated FPSA/TPSA ratio as a novel non-invasive biomarker for declining eGFR in male type 2 diabetes
PSA is a blood test normally used to check the prostate. In men with type 2 diabetes, this study found that a higher ratio of free PSA to total PSA went along with a faster drop in kidney filtering rate (eGFR). That is a link, not proof that one causes the other. It would need checking in other groups of men before any doctor used it to flag kidney decline early.
Multi-Omics Mendelian Randomization Maps Lipid-Related Brain Cell-Type Associations with Kidney Disease
Researchers used gene differences people are born with as a kind of natural experiment, looking for ties between blood fats, specific brain cell types, and kidney disease. They report that fat related signals in certain brain cells track with kidney disease risk. This method hints at cause better than a plain survey, but no one was treated and nothing was tested. It shows a link worth chasing, not proof, and it changes nothing about care today.
Lipid parameters and the risk of incident CKD: an analysis of conventional and composite lipid indices
This study checked whether blood fat levels predict who later develops chronic kidney disease. It tested familiar measures like cholesterol and triglycerides along with combined scores that mix several blood fats into one number. It follows people over time without changing anything, so it shows a link between blood fats and kidney disease, not proof that one causes the other. The size of the risk and the number of people followed were not in the record available here.
SERUM VITAMIN D LEVELS AMONG PATIENTS WITH RENAL FAILURE COMPARED TO HEALTHY CONTROLS IN GEZIRA STATE, SUDAN
This study measured vitamin D in the blood of people with kidney failure and compared it with healthy people in Gezira State, Sudan. Damaged kidneys struggle to turn vitamin D into the active form the body uses, so low levels are common in kidney disease. The study compares two groups at a single point in time, so it shows a link, not proof of cause. The number of people tested and the measured levels were not in the record available here.
THYROID DYSFUNCTION IN PATIENTS OF CHRONIC KIDNEY DISEASE -AN OBSERVATION STUDY
In this study, people with long-term kidney disease often had a thyroid that was running slow. The thyroid is the neck gland that sets your body's pace, and a slow one causes tiredness, cold and weight gain, symptoms easy to blame on kidney disease alone. This study only watched patients, so it shows a link, not proof that one causes the other. The report does not say how many people were checked.
ASSOCIATION OF SERUM URIC ACID WITH RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
This study looked at whether uric acid, a waste product in the blood that also causes gout, tracks with kidney filtering in people who already have chronic kidney disease. No abstract came with the record, so the number of people and the size of any link are not available here. A study built this way can only show an association. It cannot show that uric acid damages kidneys, or that lowering it would help.
Acute kidney injury during ruxolitinib therapy in pediatric patients with graft-versus-host disease: incidence, associated factors, and histopathological findings in a retrospective cohort study
Ruxolitinib is a drug given for graft-versus-host disease, a complication after a bone marrow transplant. Researchers looked back through the records of children on this drug to count how many had sudden kidney injury, what made it more likely, and what the kidney tissue looked like under a microscope. No abstract was posted with this record, so the counts are not available here. A look-back study like this shows a link between the drug and kidney trouble, not proof that the drug caused it, because these children are very ill in several ways at once.
Association Between Physical Therapy and Mortality in Older Patients with Heart Failure and Chronic Kidney Disease
This study looked at older people who have both heart failure and chronic kidney disease, and asked whether those who received physical therapy lived longer. Physical therapy here means supervised exercise and movement training. It is an observational study, so it shows a link, not proof that the therapy caused the lower death rate. People healthy enough to be sent to therapy tend to do better anyway. The abstract was not available, so the number of patients and the follow-up time are not known here.
Penerapan Terapi Relaksasi Benson Dan Terapi Isometrik Terhadap Penurunan Fatigue Pada Ny.E Dengan Chronic Kidney Disease
This is a nursing case report on one woman with chronic kidney disease who was tired all the time. She was given Benson relaxation, a simple method of slow breathing while repeating a calming word, along with isometric exercise, where muscles tense without moving. The report says her fatigue went down. One person, no comparison group, and no measured kidney numbers: this cannot show the therapy caused anything.
Family involvement and shared decision-making quality in renal replacement therapy selection: a nationwide cross-sectional study
A nationwide survey asked people with kidney failure how much their family took part when they chose a treatment, such as dialysis or a transplant. More family involvement went with patients rating the decision making as better shared with their care team. The survey captured one moment in time, so it shows a link, not proof that involving family causes better decisions.
Outcomes by Dialysis Modality in a Safety-Net Population: A 10-Year Retrospective Cohort Study.
This study followed people on dialysis at safety-net hospitals, which serve patients with little or no insurance, over 10 years. It compared how people did on different types of dialysis. Because it looks back at old records, it can show a link between the type of dialysis and how people did, not proof that one type causes better results. The full report was not available in this sweep, so the number of patients and the actual findings are not known yet.
Admission versus historical serum creatinine alters AKI classification in cirrhosis: a retrospective study of MIMIC-IV and eICU-CRD
Doctors decide that kidneys have been suddenly injured by comparing creatinine, a waste marker in the blood, against a starting value. Using hospital records from people with liver scarring (cirrhosis), this study found that using the creatinine measured at admission, rather than an older one from before, changes who gets labeled as kidney-injured. That is a link between the baseline you pick and the diagnosis you get, not proof that either choice is the right one. It matters because the label drives the treatment a person receives.
Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study.
Most people with kidney disease become anemic, meaning they have too few red blood cells, which causes deep tiredness. Two hormones drive this: hepcidin, which locks iron away, and erythropoietin (EPO), which tells the body to make red cells. Researchers measured both in 100 people with kidney disease who did not have diabetes. Everyone was tested at a single point in time, so this shows how the hormones and anemia travel together, not which one causes the other.
Assessing the Prevalence and Pattern of Dyslipidemia Among Maintenance Hemodialysis Patients in Selected Areas of Bangladesh: A Multicenter Cross-Sectional Study.
Heart and artery disease causes 40 to 50 percent of deaths in people with failed kidneys. This study measured blood fats in people on regular dialysis at several centers in Bangladesh, looking for low HDL (the protective cholesterol) and high triglycerides (a blood fat). Everyone was tested once, so it describes how common the problem is in this group. It cannot show that these blood fats cause the heart deaths.